Endemic mycoses in immunocompromised hosts
- PMID: 24197921
- PMCID: PMC4939090
- DOI: 10.1007/s11908-013-0387-4
Endemic mycoses in immunocompromised hosts
Abstract
Endemic mycoses remain a significant cause of morbidity and mortality among immunocompromised patients. As the number of immunosuppressed individuals increases worldwide, the incidence of endemic mycoses is also expected to rise. In immunocompromised patients, endemic mycoses can present in atypical fashion, cause more severe and/or disseminated disease, and result in higher mortality. Despite several noteworthy advances over the past decade, significant challenges remain with regard to the prevention, diagnosis, and therapy of endemic mycoses in immunocompromised hosts. This review highlights important developments related to the epidemiology, diagnosis, treatment, and prevention of commonly encountered endemic mycoses. We also discuss emerging topics, knowledge gaps, and areas of future research.
Conflict of interest statement
Trent R. Malcolm and Peter V. Chin-Hong declare that they have no conflict of interest.
References
-
- Hsu LY, Ng ES, Koh LP. Common and emerging fungal pulmonary infections. Infect Dis Clin North Am. 2010;24(3):557–577. - PubMed
-
- Kauffman CA. Endemic mycoses: blastomycosis, histoplasmosis, and sporotrichosis. Infect Dis Clin North Am. 2006;20(3):645–662. vii. - PubMed
-
- Pfaller MA, Diekema DJ. Epidemiology of invasive mycoses in North America. Crit Rev Microbiol. 2010;36(1):1–53. - PubMed
-
- Grim SA, et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis. 2012;14(1):17–23. - PubMed
-
- Ramos-e-Silva M, et al. Systemic mycoses in immunodepressed patients (AIDS) Clin Dermatol. 2012;30(6):616–627. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
